Literature DB >> 19438916

Underdiagnosis and undertreatment of migraine in Italy: a survey of patients attending for the first time 10 headache centres.

S Cevoli1, D D'Amico, P Martelletti, F Valguarnera, E Del Bene, R De Simone, P Sarchielli, Mc Narbone, L Testa, S Genco, G Bussone, P Cortelli.   

Abstract

The aim of this study was to asses the clinical features, pattern of healthcare and drug utilization of migraine patients attending 10 Italian headache centres (HC). Migraine is underdiagnosed and undertreated everywhere throughout the world, despite its considerable burden. Migraine sufferers often deal with their problem alone using self-prescribing drugs, whereas triptans are used by a small proportion of patients. All patients attending for the first time 10 Italian HCs over a 3-month period were screened for migraine. Migraine patients underwent a structured direct interview about previous migraine diagnosis, comorbidity, headache treatments and their side-effects and healthcare utilization for migraine. Patient satisfaction with their usual therapy for the migraine attack was evaluated with the Migraine-Assessment of Current Therapy (ACT) questionnaire. The quality of life of migraine patients was assessed by mean of Short Form (SF)-12 and Migraine-Specific Quality of life (MSQ) version 2.1 questionnaires. Of the 2675 patients who attended HCs for the first time during the study period, 71% received a diagnosis of migraine and the first 953 subjects completed the study out of 1025 patients enrolled. Only 26.8% of migraine patients had a previous diagnosis of migraine; 62.4% of them visited their general practitioner (GP) in the last year, 38.2% saw a specialist for headache, 23% attended an Emergency Department and 4.5% were admitted to hospital for migraine; 82.8% of patients used non-specific drugs for migraine attacks, whereas 17.2% used triptans and only 4.8% used a preventive migraine medication. Triptans were used by 46.4% of patients with a previous diagnosis of migraine. About 80% of migraine patients took over-the-counter medications. The Migraine-ACT revealed that 60% of patients needed a change in their treatment of migraine attacks, 85% of whom took non-specific drugs. Both the MSQ version 2.1 and the SF-12 questionnaires indicated a poor quality of life of most patients. Migraine represents the prevalent headache diagnosis in Italian HCs. Migraine is still underdiagnosed in Italy and migraine patients receive a suboptimal medical approach in our country, despite the healthcare utilization of migraine subjects being noteworthy. A cooperative network involving GPs, neurologists and headache specialists is strongly desirable in order to improve long-term migraine management in Italy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19438916     DOI: 10.1111/j.1468-2982.2009.01874.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  35 in total

1.  SPARTACUS: underdiagnosis of chronic daily headache in primary care.

Authors:  G Giannini; V Favoni; S Bauleo; T Ferrante; G Pierangeli; F Albani; M L Bacchi Reggiani; A Baruzzi; P Cortelli; S Cevoli
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

2.  Validating the Migraine-Specific Quality of Life Questionnaire v2.1 (MSQ) in Italian inpatients with chronic migraine with a history of medication overuse.

Authors:  Alberto Raggi; Ambra Mara Giovannetti; Silvia Schiavolin; Matilde Leonardi; Gennaro Bussone; Licia Grazzi; Susanna Usai; Marcella Curone; Paola Di Fiore; Domenico D'Amico
Journal:  Qual Life Res       Date:  2013-10-16       Impact factor: 4.147

3.  Headache in a population of hospital workers.

Authors:  G Viticchi; L Falsetti; P Pettinari; L Provinciali; M Silvestrini; M Bartolini
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

4.  Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients.

Authors:  Jelena M Pavlovic; Justin S Yu; Stephen D Silberstein; Michael L Reed; Steve H Kawahara; Robert P Cowan; Firas Dabbous; Karen L Campbell; Anand R Shewale; Riya Pulicharam; Jonathan W Kowalski; Hema N Viswanathan; Richard B Lipton
Journal:  Cephalalgia       Date:  2019-03-09       Impact factor: 6.292

5.  Italian Law "measures to guarantee the access to palliative and pain treatments": rebound on headaches' management.

Authors:  S Cevoli; P Cortelli
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

6.  Instrumental investigations and migraine diagnosis.

Authors:  Giovanna Viticchi; M Bartolini; L Falsetti; R Cerqua; C Lanciotti; L Provinciali; M Silvestrini
Journal:  Neurol Sci       Date:  2010-06       Impact factor: 3.307

7.  Prophylactic treatment of migraine by GPs: a qualitative study.

Authors:  Frans Dekker; Arie Knuistingh Neven; Boukje Andriesse; David Kernick; Michel D Ferrari; Willem J J Assendelft
Journal:  Br J Gen Pract       Date:  2012-04       Impact factor: 5.386

8.  Long-term effects of a sensitisation campaign on migraine: the Casilino study.

Authors:  B Petolicchio; L Di Clemente; M Altieri; E Vicenzini; G L Lenzi; Vittorio Di Piero
Journal:  J Headache Pain       Date:  2010-04       Impact factor: 7.277

9.  Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.

Authors:  Kenneth A Holroyd; Constance K Cottrell; Francis J O'Donnell; Gary E Cordingley; Jana B Drew; Bruce W Carlson; Lina Himawan
Journal:  BMJ       Date:  2010-09-29

10.  Taking the headache out of migraine.

Authors:  David Borsook; David W Dodick
Journal:  Neurol Clin Pract       Date:  2015-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.